Teena Lerner is a seasoned investment professional with expertise in biotechnology and healthcare. She began her career as a biotechnology analyst and hedge fund manager, accumulating nearly 20 years of experience before founding her own hedge fund firm, Rx Capital, in 2001. The firm achieved significant profitability post-startup, though it faced challenges such as a major loss from one of its analysts in 2004, as documented in a Harvard Business School case study. Lerner also serves as a Member of the Board of Directors at Applied Therapeutics Inc. (NASDAQ: APLT), a biopharmaceutical company. In addition to her finance career, Lerner is deeply involved in philanthropy. She was the Former President of the Jewish Communal Fund Board of Trustees and joined its Board as a new trustee, leveraging her background as a former biotech analyst. Her educational credentials include a BS from City University of New York-Brooklyn College, an MBA from New York University Stern School of Business, and a PhD in Molecular Biology/Retrovirology from The Rockefeller University, complemented by a CFA charter. Based in the New York City metropolitan area, Lerner's professional network spans Wall Street, biotech, and nonprofit sectors, positioning her as an influential figure in investment and communal funding circles.